Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Inaji

Showing results (261-270 of 298) with videos related to

Pageof 30
Sort By:
BMC Pediatrics|May 4, 2024
Intracranial residual lesions following early intensification in a patient with T-cell acute lymphoblastic leukemia: a case reportYuichi Nagamatsu, Takeshi Isoda, Motoki Inaji, et al.
Cancer Research|October 1, 1981
Use of human prostate-specific antigen in monitoring prostate cancerM Kuriyama, M C Wang, C I Lee, et al.
Breast Cancer Research and Treatment|December 1, 2020
Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial)Shinji Ohno, Shigehira Saji, Norikazu Masuda, et al.
Oncology Letters|April 30, 2017
Evaluation of ALDH1 expression in ipsilateral breast cancer recurrenceTadahiko Shien, Takehiro Tanaka, Masahiko Tanabe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 17, 2015
Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrenceY Okumura, R Nishimura, K Nakatsukasa, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 4, 2024
Decreased diffusivity along the perivascular space and cerebral hemodynamic disturbance in adult moyamoya diseaseShoko Hara, Junko Kikuta, Kaito Takabayashi, et al.
Cancer Letters|September 15, 2014
The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapySeung Jin Kim, Norikazu Masuda, Fumine Tsukamoto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 9, 2016
Local recurrence risk after previous salvage mastectomyM Tanabe, T Iwase, Y Okumura, et al.
In Vivo (Athens, Greece)|March 7, 2023
Preferences Regarding Breast Surgery Omission Among Patients With Breast Cancer Who Receive Neoadjuvant ChemotherapyKaho Nakamura, Makoto Ishitobi, Chiya Oshiro, et al.
Oncology|July 8, 2010
Phase II trial in Japan of sequential administration of weekly paclitaxel followed by FEC as neoadjuvant chemotherapy for locally advanced breast cancer [KBCSG0206 trial: Kinki Breast Cancer Study Group (KBCSG)]Tetsuya Taguchi, Norikazu Masuda, Takahiro Nakayama, et al.
Pageof 30

Showing results (261-270 of 298) with videos related to

Sort By:
Pageof 30
BMC Pediatrics|May 4, 2024
Intracranial residual lesions following early intensification in a patient with T-cell acute lymphoblastic leukemia: a case reportYuichi Nagamatsu, Takeshi Isoda, Motoki Inaji, et al.
Cancer Research|October 1, 1981
Use of human prostate-specific antigen in monitoring prostate cancerM Kuriyama, M C Wang, C I Lee, et al.
Breast Cancer Research and Treatment|December 1, 2020
Relationships between pathological factors and long-term outcomes in patients enrolled in two prospective randomized controlled trials comparing the efficacy of oral tegafur-uracil with CMF (N·SAS-BC 01 trial and CUBC trial)Shinji Ohno, Shigehira Saji, Norikazu Masuda, et al.
Oncology Letters|April 30, 2017
Evaluation of ALDH1 expression in ipsilateral breast cancer recurrenceTadahiko Shien, Takehiro Tanaka, Masahiko Tanabe, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|February 17, 2015
Change in estrogen receptor, HER2, and Ki-67 status between primary breast cancer and ipsilateral breast cancer tumor recurrenceY Okumura, R Nishimura, K Nakatsukasa, et al.
Journal of Cerebral Blood Flow and Metabolism : Official Journal of the International Society of Cerebral Blood Flow and Metabolism|April 4, 2024
Decreased diffusivity along the perivascular space and cerebral hemodynamic disturbance in adult moyamoya diseaseShoko Hara, Junko Kikuta, Kaito Takabayashi, et al.
Cancer Letters|September 15, 2014
The cell cycle profiling-risk score based on CDK1 and 2 predicts early recurrence in node-negative, hormone receptor-positive breast cancer treated with endocrine therapySeung Jin Kim, Norikazu Masuda, Fumine Tsukamoto, et al.
European Journal of Surgical Oncology : the Journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology|April 9, 2016
Local recurrence risk after previous salvage mastectomyM Tanabe, T Iwase, Y Okumura, et al.
In Vivo (Athens, Greece)|March 7, 2023
Preferences Regarding Breast Surgery Omission Among Patients With Breast Cancer Who Receive Neoadjuvant ChemotherapyKaho Nakamura, Makoto Ishitobi, Chiya Oshiro, et al.
Oncology|July 8, 2010
Phase II trial in Japan of sequential administration of weekly paclitaxel followed by FEC as neoadjuvant chemotherapy for locally advanced breast cancer [KBCSG0206 trial: Kinki Breast Cancer Study Group (KBCSG)]Tetsuya Taguchi, Norikazu Masuda, Takahiro Nakayama, et al.
Pageof 30